Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data
Titel:
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data
Auteur:
Sehn, Laurie H. Hertzberg, Mark Opat, Stephen Herrera, Alex F. Assouline, Sarit Flowers, Christopher R. Kim, Tae Min McMillan, Andrew Ozcan, Muhit Safar, Violaine Salles, Gilles Ku, Grace Hirata, Jamie Chang, Yi Meng Musick, Lisa Matasar, Matthew J.